ScreenerHero
ATRAptarGroup, Inc.
NYSE · US · Consumer Cyclical · Medical Instruments & Supplies · aptar.com
133.97USD+0.78%Mkt Cap: 8.45B $P/E: 23.95

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care,…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Societe anonyme
$80.53BUSDP/E 30.2
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon AG
$32.71BUSDP/E 55.9
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech
$20.62BUSDP/E 64.6
SRT3
Sartorius Aktiengesellschaft
$18.68BUSDP/E 87.6
STMN
Straumann Holding AG
$17.47BUSDP/E 41.6
SRT
Sartorius Aktiengesellschaft
$15.01BUSDP/E 70.4
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
YPSN
Ypsomed Holding AG
$6.15BUSDP/E 25.1
STVN
Stevanato Group S.p.A.
$6.10BUSDP/E 39.2

Key Statistics

Company
Market Cap8.45B $
Enterprise Value9.71B $
Revenue (TTM)3.93B $
Gross Profit1.40B $
Net Income (TTM)392.79M $
Revenue/Share60.89 USD
Last Price133.97 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14.0K
CountryUS
SectorConsumer Cyclical
IndustryMedical Instruments & Supplies
ISINUS0383361039
Valuation
P/E (Trailing)23.95
P/E (Forward)21.05
PEG2.37
EV/EBITDA12.17
EV/Revenue2.47
P/S2.15
P/B3.22
EPS (TTM)5.54
EPS (Forward)6.32
52W Range
103.2370% of range146.91
52W High146.91 USD
52W Low103.23 USD
Profitability
Gross Margin37.19%
Oper. Margin12.49%
EBITDA Margin20.30%
Profit Margin10.40%
ROE14.72%
ROA7.48%
Growth
Revenue Growth6.30%
Earnings Growth-18.60%
Cash Flow & Leverage
Operating CF570.00M $
CapEx (TTM)275.44M $
FCF Margin6.76%
FCF Yield3.15%
Net Debt1.21B $
Net Debt/EBITDA1.52
Balance Sheet
Debt/Equity0.57
Current Ratio1.61
Quick Ratio0.98
Book Value/Sh41.33 USD
Cash/Share3.103 USD
Dividends
Fwd Div Rate1.920 USD
Trail. Div Rate1.890 USD
Div. Yield1.44%
5Y Avg Yield1.27%
Payout Ratio34.12%
Ex-Div DateJul 30, 2026
Pay DateAug 20, 2026
Splits
Last Split2:1
Split DateMay 10, 2007
Analyst Consensus
Rating—
Target (Mean)170.14 USD
Upside (mean)+27.0%
Target Range155.00 USD – 220.00 USD
$155.00+27.0% to mean$220.00
# Analysts7
Ownership
Shares Out.63.58M
Float62.96M
Insiders0.86%
Institutions99.18%
Short Interest
Short Ratio3.9d
Short % Float3.28%
Short % Out.2.89%
Shares Short1.84M
Short (prev mo.)1.83M
Technical
SMA 50128.53 (+4.2%)
SMA 200125.68 (+6.6%)
Beta0.38
S&P 52W Chg18.16%
Avg Vol (30d)370.40K
Avg Vol (10d)435.01K
Technical Indicators
RSI (14)53.0
MACD1.2585
MACD Signal2.0427
MACD Hist.-0.7841
BB Upper138.68 USD
BB Middle133.88 USD
BB Lower129.08 USD
BB Width7.17%
ATR (14)2.956 USD
Vol Ratio (20d)0.76x